Bard Peripheral Vascular Inc, Pay Nearly, Resolve False Claims Act — Semler Scientific Inc. and Bard Peripheral Vascular Inc. to Pay Nearly $37M to Resolve False Claims Act Allegations Relating to FloChec and QuantaFlo Devices | United States Justice Department.
Kehoe for the Middle District of Florida. to Pay Nearly $37M to Resolve False Claims Act Allegations Relating to FloChec and QuantaFlo Devices Friday, September 26, 2025 Share Facebook X LinkedIn Email For Immediate Release Office of Public Affairs Semler Scientific Inc. and Bard Peripheral Vascular Inc. “When critical information is misrepresented or skewed for profit or personal gain, the limited resources available for our healthcare system are diminished.”“Medical device companies that misrepresent the capabilities of their products and encourage providers to bill Medicare for services that do not meet coverage requirements
drain critical taxpayer-funded resources,” said Acting Special Agent in Charge Isaac M. West will receive approximately $6.5 million as their share of the recovery.The government’s resolution of this matter illustrates the government’s emphasis on combating health care fraud. and its related companies, has agreed to pay $7.2 million to resolve allegations that they violated the False Claims Act, 31 U.S.C. announcement Semler Scientific Inc. §§ 3729-3733, by knowingly causing, and conspiring to cause, the submission of false claims to Medicare for photoplethysmography tests performed using the FloChec and QuantaFlo devices in connection
with the diagnosis of peripheral arterial disease (PAD).“Medicare billing regulations are created, in part, to protect the public fisc,” said Assistant Attorney General Brett A. Tips and complaints from all sources about potential fraud, waste, abuse, and mismanagement can be reported to the Department of Health and Human Services at 800-HHS-TIPS (800-447-8477).The settlement resulted from a coordinated effort among the Civil Division’s Fraud Section and the U.S. Attorney Gregory W. Bledsoe of the Department of Health and Human Services Office of Inspector General (HHS-OIG). “In addition to this settlement, HHS-OIG has entered into a new five-year